• Novartis Resolves Legacy FCPA Investigations americanpharmaceuticalreview
    July 07, 2020
    Novartis has reached settlements with the US Department of Justice (DOJ) and the US Securities and Exchange Commission (SEC) resolving all Foreign Corrupt Practices Act (FCPA) investigations into historical conduct by the Company and its subsidiaries.
PharmaSources Customer Service